Metraipolis › archive › dc_4196381cc322

MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and… — Europe PMC PMID:42164509

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42164509
DOI
10.3389/fimmu.2026.1789537
License (as archived)
solo-consultazione
Archived
2026-11-02T18:00:28.714Z
SHA-256 of the archived text
081f3feb236766af905c86cb219c1a164f9bf9f42bd351c67f01a1bd692a4f6a
Stable URL of this page
https://metraipolis.com/documento/dc_4196381cc322

How to cite

MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and… — Europe PMC PMID:42164509 — Europe PMC (en), https://europepmc.org/article/MED/42164509 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4196381cc322 (Metraipolis archive dc_4196381cc322, sha256 081f3feb236766af905c86cb219c1a164f9bf9f42bd351c67f01a1bd692a4f6a)
BibTeX
@misc{dc4196381cc322,
  title = {MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and… — Europe PMC PMID:42164509},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42164509},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4196381cc322; sha256 081f3feb236766af905c86cb219c1a164f9bf9f42bd351c67f01a1bd692a4f6a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42164509. Agents can read the archived copy with the MCP tool read_document.